-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
BriaCell Therapeutics Corp. quarterly and annual Nonoperating Income (Expense) history and change rate from 2021 to Q2 2025.
- BriaCell Therapeutics Corp. Nonoperating Income (Expense) for the quarter ending 31 Jul 2025 was $45,201.
- BriaCell Therapeutics Corp. Nonoperating Income (Expense) for the twelve months ending 31 Jul 2025 was $114,511, a 56.4% decline year-over-year.
- BriaCell Therapeutics Corp. annual Nonoperating Income (Expense) for 2025 was $114,511, a 56.4% decline from 2024.
- BriaCell Therapeutics Corp. annual Nonoperating Income (Expense) for 2024 was $262,566, a 69.1% decline from 2023.
- BriaCell Therapeutics Corp. annual Nonoperating Income (Expense) for 2023 was $850,340.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)